Dr. Beitle joined the Department of Chemical Engineering at the UA in August 1993. In 1998 he was awarded tenure and promoted to Associate Professor, and in 2006 he achieved the rank of Full Professor. His primary research interests are in the field of biochemical engineering, with an emphasis on bioseparation and fermentation, and adaptive technology for the disabled. 

Dr. Beitle teaches upper level and graduate level courses in chemical engineering, and enjoys challenging students to apply their fundamental learning in a variety of settings. He has received teaching awards both as a graduate student (1988) and as a faculty member (1998, 2003, and 2007), and has been recognized as an outstanding mentor at the University of Arkansas three times. He is a member of the American Institute of Chemical Engineers, the American Chemical Society, and various other technical and honorary societies. He has served on the Executive Committee for the Biochemical Technology Division within ACS, and is a longstanding member of the Cell and Molecular Biology Program Advisory Committee at the University of Arkansas.

Dr. David McNabb has been a University of Arkansas faculty member for more than 22 years.  He currently serves on its University Toxic Substances, Communicable Disease Outbreak, and University Building Facilities committees. Dr. McNabb has been widely recognized by the University of Arkansas and Fulbright College for his dedication to students and excellence in teaching; he has received the University’s Outstanding Mentor Award 14 times, been inducted as a University of Arkansas Teaching Fellow, and was a past recipient of the college’s Master Teacher Award. 

Dr. McNabb holds a B.S. in microbiology from the University of Texas at Arlington, and a Ph.D. in biochemistry and molecular biology from Louisiana State University Medical Center. His research interests center on the development and identification of antifungal compounds or peptides for potential use in the treatment of fungal infections in humans, determining the role of the CCAAT-binding factor in Candida albicans pathogenesis, and the application of solid-state nanopores as single molecule detectors for applications in biological systems. 

Additionally, Dr. McNabb has received millions in research funding from organizations including the National Institutes of Health, the National Science Foundation, the Howard Hughes Medical Institute, the Arkansas Biosciences Institute, the American Heart Association, the U.S. Food and Drug Administration, and more.  He also holds four U.S. patents for his collaborative research, has authored or co-authored dozens of articles in top journals, and serves as an ad hoc reviewer for multiple scientific journals and cell and molecular biology textbooks.  Dr. McNabb is also a member of the American Heart Association’s Council on Genomics and Precision Medicine, the American Chemical Society’s Biological Chemistry Division, Sigma Xi, the Genetics Society of America and the American Society for Microbiology.